Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

GLOBAL MARKETS-Stocks rise as Biden transition, vaccine progress lift confidence

Published 24/11/2020, 01:42 pm
© Reuters.

* AstraZeneca vaccine news drives risk-on approach

* Vaccine could be released by mid-December

* Trump, government officials nod to formal Biden transition

* For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

*

By Katanga Johnson and Julie Zhu

WASHINGTON/HONG KONG, Nov 24 (Reuters) - Asian shares climbed on Tuesday as news U.S. President-elect Joe Biden was given the go-ahead to begin his White House transition added to an already brighter mood from progress made on COVID-19 vaccine and the prospects for a speedy global economic revival

U.S. General Services Administration chief Emily Murphy wrote in a letter to Biden on Monday that he can formally begin the hand-over process.

President Donald Trump tweeted that he had told his team "do what needs to be done with regard to initial protocols", an indication he was moving toward a transition after weeks of legal challenges to the election results. stocks also got an added boost after reports that Biden plans to nominate former Federal Reserve Chair, Janet Yellen, to become the next Treasury Secretary. Futures for the S&P 500 EScv1 rose 0.48% in early Asian trade. upbeat backdrop helped MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS advance 0.15%. Australia's S&P/ASX 200 .AXJO was 1.1% stronger, touching its highest level in almost nine months, with energy stocks leading the pack. Nikkei .N225 jumped 2.48% while Seoul's Kospi .KS11 was 0.74% higher.

Chinese blue-chips .CSI300 and Hong Kong's Hang Seng .HSI were however outliers, edging down 0.75% and 0.08%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The progress made on COVID-19 vaccines, which had underpinned Wall Street overnight, helped keep risk appetite elevated as it boosted optimism about a quicker revival for the global economy.

AstraZeneca AZN.L said its COVID-19 vaccine, cheaper to make, easier to distribute and faster to scale-up than its rivals, could be as much as 90% effective. are still buying into vaccine news clearance, as the end of the pandemic becomes imaginable. Recent U.S. data restored a bit of confidence that the economy is holding up, despite surging COVID-19 infections and a painful lack of fresh fiscal stimulus," said Kyle Rodda, a market analyst for IG Australia.

"And the news of Yellen's possible nomination to the role of U.S. Treasury Secretary potentially puts a very Fed-friendly uber-dove at the reins of fiscal policy."

The U.S. dollar index touched its lowest since Sept. 1 before edging 0.214% higher with the euro EUR= unchanged at $1.184.

On Wall Street, the Dow Jones Industrial Average .DJI rose 1.12% overnight, the S&P 500 .SPX gained 0.56% while the Nasdaq Composite .IXIC added only 0.22%, underperforming as traders rotated away from big tech names.

Some analysts expect big, short-term risks ahead of the U.S. Thanksgiving holiday, although others say unexpected news events at the start of the shorter trading week helped investors focus on the growing positives for financial markets.

Oil prices added to last week's gains as traders anticipated the vaccine news would spur a recovery in energy demand.

"Investors are ignoring near-term headwinds, chief among which are surging global COVID infections, and instead looking ahead to next summer," said PVM analyst Stephen Brennock.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The United States surpassed 255,000 deaths and 12 million infections since the pandemic began, with daily infections at a record near 170,000 and daily deaths around 1,500.

U.S. crude CLc1 advanced 0.14% to $43.12 per barrel and Brent LCOc1 was at $46.10, up 0.09% on Tuesday, while an index of commodity prices .TRCCRB touched its highest since early March.

The yield on the benchmark 10-year notes US10YT=RR rose slightly to 0.8684%.

Spot gold XAU= fell to $1,827.01 an ounce while U.S. gold futures GCc1 dropped 0.46% to $1,829.30 an ounce.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.